# Uncontrolled Study to Evaluate Efficacy of Tocilizumab in Patients With Moderate or Severe Rheumatoid Arthritis

> **NCT02087696** · PHASE4 · UNKNOWN · sponsor: **Spanish Foundation of Rheumatology** · enrollment: 122 (estimated)

## Conditions studied

- Arthritis, Rheumatoid

## Interventions

- **DRUG:** Tocilizumab

## Key facts

- **NCT ID:** NCT02087696
- **Lead sponsor:** Spanish Foundation of Rheumatology
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2014-05
- **Primary completion:** 2015-12
- **Final completion:** 2016-07
- **Target enrollment:** 122 (ESTIMATED)
- **Last updated:** 2015-05-22

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02087696

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02087696, "Uncontrolled Study to Evaluate Efficacy of Tocilizumab in Patients With Moderate or Severe Rheumatoid Arthritis". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT02087696. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*